A citation-based method for searching scientific literature


List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Kenichi Nakanishi, Toyone Kikumori, Noriyuki Miyajima, Yuko Takano, Sumiyo Noda, Dai Takeuchi, Shingo Iwano, Yasuhiro Kodera. Clin Nucl Med 2018
6
50

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
50

Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study.
Renfei Wang, Yueqian Zhang, Jian Tan, Guizhi Zhang, Ruiguo Zhang, Wei Zheng, Yajing He. Medicine (Baltimore) 2017
14
50



Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Hong-Jun Song, Zhong-Ling Qiu, Chen-Tian Shen, Wei-Jun Wei, Quan-Yong Luo. Eur J Endocrinol 2015
69
50

Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.
Takuro Isoda, Shingo BaBa, Yasuhiro Maruoka, Yoshiyuki Kitamura, Keiichiro Tahara, Masayuki Sasaki, Hiroshi Honda. Ann Nucl Med 2016
4
50


Efficacy and safety of bevacizumab for the treatment of glioblastoma.
Zhiyun Yu, Gang Zhao, Zhonghua Zhang, Yunqian Li, Yong Chen, Nan Wang, Zhongying Zhao, Guifang Xie. Exp Ther Med 2016
9
25

Bevacizumab in brain tumors: ready for primetime?
Enrico Franceschi, Alicia Tosoni, Fabio Girardi, Alba A Brandes. Future Oncol 2009
5
25

Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.
Yongjun Cheng, Jinhua Zhao, Wenli Qiao, Kai Chen. Am J Nucl Med Mol Imaging 2014
29
25


Current Consensus on I-131 MIBG Therapy.
Daiki Kayano, Seigo Kinuya. Nucl Med Mol Imaging 2018
34
25

Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk.
Su Kang Kim, Sang Wook Kang, Hae Jeong Park, Ju Yeon Ban, Chung-Hun Oh, Joo-Ho Chung, In-Hwan Oh, Kyu Bong Cho, Min-Su Park. Int J Clin Exp Med 2015
5
25

Use of chlorotoxin for targeting of primary brain tumors.
L Soroceanu, Y Gillespie, M B Khazaeli, H Sontheimer. Cancer Res 1998
171
25

Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Adam N Mamelak, Steven Rosenfeld, Richard Bucholz, Andrew Raubitschek, L Burt Nabors, John B Fiveash, Sui Shen, M B Khazaeli, David Colcher, An Liu,[...]. J Clin Oncol 2006
148
25

Tumor suppression by stromal TIMPs.
Masayuki Shimoda, Hartland W Jackson, Rama Khokha. Mol Cell Oncol 2016
11
25

Matrix metalloproteinases: regulators of the tumor microenvironment.
Kai Kessenbrock, Vicki Plaks, Zena Werb. Cell 2010
25

Recurrent glioblastoma multiforme: a review of natural history and management options.
Lewis C Hou, Anand Veeravagu, Andrew R Hsu, Victor C K Tse. Neurosurg Focus 2006
186
25

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
George Sgouros, Katherine S Kolbert, Arif Sheikh, Keith S Pentlow, Edward F Mun, Axel Barth, Richard J Robbins, Steven M Larson. J Nucl Med 2004
205
25


Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas.
Yue-Jun Fu, Li-Tian Yin, Ai-Hua Liang, Chao-Feng Zhang, Wei Wang, Bao-Feng Chai, Jian-Yi Yang, Xiao-Jun Fan. Neurosci Lett 2007
49
25


Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent.
Jinhua Zhao, Wenli Qiao, Yuna Zhang, Xiaoxia Shao. Cancer Biother Radiopharm 2010
10
25

Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Lisa M Coussens, Barbara Fingleton, Lynn M Matrisian. Science 2002
25


Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
Kathrin Klutz, David Schaffert, Michael J Willhauck, Geoffrey K Grünwald, Rudolf Haase, Nathalie Wunderlich, Christian Zach, Franz J Gildehaus, Reingard Senekowitsch-Schmidtke, Burkhard Göke,[...]. Mol Ther 2011
83
25

Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
Sui Shen, M B Khazaeli, G Yancey Gillespie, Vernon L Alvarez. J Neurooncol 2005
34
25

Genetics of adult glioma.
McKinsey L Goodenberger, Robert B Jenkins. Cancer Genet 2012
515
25

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Magdalena Groblewska, Maria Siewko, Barbara Mroczko, Maciej Szmitkowski. Folia Histochem Cytobiol 2012
115
25

Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
Martin Schlumberger, Bogdan Catargi, Isabelle Borget, Désirée Deandreis, Slimane Zerdoud, Boumédiène Bridji, Stéphane Bardet, Laurence Leenhardt, Delphine Bastie, Claire Schvartz,[...]. N Engl J Med 2012
402
25

Flavonoids and genomic instability induced by ionizing radiation.
Seyed Jalal Hosseinimehr. Drug Discov Today 2010
56
25

A neurocentric perspective on glioma invasion.
Vishnu Anand Cuddapah, Stefanie Robel, Stacey Watkins, Harald Sontheimer. Nat Rev Neurosci 2014
446
25

Imaging glioma extent with 131I-TM-601.
David C Hockaday, Sui Shen, John Fiveash, Andrew Raubitschek, David Colcher, An Liu, Vern Alvarez, Adam N Mamelak. J Nucl Med 2005
65
25


Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients.
M Leo, E Sabini, I Ionni, A Sframeli, B Mazzi, F Menconi, E Molinaro, F Bianchi, F Brozzi, P Santini,[...]. J Endocrinol Invest 2018
4
25

131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
Angela Spanu, Maria E Solinas, Francesca Chessa, Daniela Sanna, Susanna Nuvoli, Giuseppe Madeddu. J Nucl Med 2009
100
25

BmKCT toxin inhibits glioma proliferation and tumor metastasis.
Shaozhong Fan, Zhengbo Sun, Dahe Jiang, Chao Dai, Yibao Ma, Zhenhuan Zhao, Hui Liu, Yingliang Wu, Zhijian Cao, Wenxin Li. Cancer Lett 2010
46
25

TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis.
P Valente, G Fassina, A Melchiori, L Masiello, M Cilli, A Vacca, M Onisto, L Santi, W G Stetler-Stevenson, A Albini. Int J Cancer 1998
233
25

Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2.
Jessy Deshane, Craig C Garner, Harald Sontheimer. J Biol Chem 2003
288
25


How matrix metalloproteinases regulate cell behavior.
M D Sternlicht, Z Werb. Annu Rev Cell Dev Biol 2001
25


Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Rita C S Figueira, Luciana R Gomes, João S Neto, Fabricio C Silva, Ismael D C G Silva, Mari C Sogayar. BMC Cancer 2009
111
25

The role of the organ microenvironment in the biology and therapy of cancer metastasis.
Isaiah J Fidler, Sun-Jin Kim, Robert R Langley. J Cell Biochem 2007
98
25

Biology and biochemistry of proteinases in tumor invasion.
P Mignatti, D B Rifkin. Physiol Rev 1993
25

Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?
Dorina Ylli, Kenneth D Burman, Douglas Van Nostrand, Leonard Wartofsky. J Clin Endocrinol Metab 2018
8
25


Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database.
Ryan K Orosco, Timon Hussain, Kevin T Brumund, Deborah K Oh, David C Chang, Michael Bouvet. Thyroid 2015
89
25

Thyroid stunning in vivo and in vitro.
Mario Medvedec. Nucl Med Commun 2005
44
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.